ArticleActa pharmaceutica Sinica. B2019

MCC1019, a selective inhibitor of the Polo-box domain of Polo-like kinase 1 as novel, potent anticancer candidate.

Sara Abdelfatah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.